| Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy DG DeNardo, DJ Brennan, E Rexhepaj, B Ruffell, SL Shiao, SF Madden, ... Cancer discovery 1 (1), 54-67, 2011 | 1873 | 2011 |
| Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis C Clarke, SF Madden, P Doolan, ST Aherne, H Joyce, L O’driscoll, ... Carcinogenesis 34 (10), 2300-2308, 2013 | 446 | 2013 |
| Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells K Weiner‐Gorzel, E Dempsey, M Milewska, A McGoldrick, V Toh, A Walsh, ... Cancer medicine 4 (5), 745-758, 2015 | 172 | 2015 |
| Proteomic portrait of human breast cancer progression identifies novel prognostic markers T Geiger, SF Madden, WM Gallagher, J Cox, M Mann Cancer research 72 (9), 2428-2439, 2012 | 166 | 2012 |
| BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome SF Madden, C Clarke, P Gaule, ST Aherne, N O'Donovan, M Clynes, ... Breast cancer research 15, 1-14, 2013 | 153 | 2013 |
| Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression ST Aherne, SF Madden, DJ Hughes, B Pardini, A Naccarati, M Levy, ... BMC cancer 15, 1-13, 2015 | 103 | 2015 |
| Integrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate C Clarke, M Henry, P Doolan, S Kelly, S Aherne, N Sanchez, P Kelly, ... BMC genomics 13, 1-14, 2012 | 101 | 2012 |
| miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro L Mulrane, SF Madden, DJ Brennan, G Gremel, SF McGee, S McNally, ... Clinical cancer research 18 (24), 6702-6713, 2012 | 92 | 2012 |
| Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer B Li, T Ni Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ... Cancer research 77 (14), 3834-3845, 2017 | 91 | 2017 |
| Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression A Henger, M Kretzler, P Doran, M Bonrouhi, H Schmid, E Kiss, CD Cohen, ... Kidney international 65 (3), 904-917, 2004 | 87 | 2004 |
| ADAM10: a new player in breast cancer progression? M Mullooly, PM McGowan, SA Kennedy, SF Madden, J Crown, ... British journal of cancer 113 (6), 945-951, 2015 | 84 | 2015 |
| Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells F Caiazza, A Murray, SF Madden, NC Synnott, EJ Ryan, N O’Donovan, ... Endocrine-related cancer 23 (4), 323-334, 2016 | 81 | 2016 |
| Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung MO Leonard, K Howell, SF Madden, CM Costello, DG Higgins, CT Taylor, ... American journal of respiratory and critical care medicine 178 (9), 977-983, 2008 | 79 | 2008 |
| ADAM-17: a novel therapeutic target for triple negative breast cancer PM McGowan, M Mullooly, F Caiazza, S Sukor, SF Madden, AA Maguire, ... Annals of oncology 24 (2), 362-369, 2013 | 76 | 2013 |
| Bidirectional KCNQ1: β-catenin interaction drives colorectal cancer cell differentiation R Rapetti-Mauss, V Bustos, W Thomas, J McBryan, H Harvey, N Lajczak, ... Proceedings of the National Academy of Sciences 114 (16), 4159-4164, 2017 | 74 | 2017 |
| Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology M Kretzler, CD Cohen, P Doran, A Henger, S Madden, EF Gro, PJ Nelson, ... Journal of the American Society of Nephrology 13 (7), 1961-1972, 2002 | 67 | 2002 |
| ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion AC Moss, G Lawlor, D Murray, D Tighe, SF Madden, AM Mulligan, ... Biochemical and biophysical research communications 345 (1), 216-221, 2006 | 65 | 2006 |
| Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19) DJ Ryan, S Toomey, SF Madden, M Casey, OS Breathnach, PG Morris, ... Thorax 76 (1), 86-88, 2021 | 64 | 2021 |
| 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer R Saldova, E Dempsey, M Pérez-Garay, K Mariño, JA Watson, ... Epigenetics 6 (11), 1362-1372, 2011 | 60 | 2011 |
| Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007 NC Synnott, MR Bauer, S Madden, A Murray, R Klinger, N O'Donovan, ... Cancer letters 414, 99-106, 2018 | 58 | 2018 |
